Continuity of CVD treatment during the COVID-19 pandemic: evidence from East Java, Indonesia

Figures & data

Fig. 1 Flow of medicines in the primary health care system

Table 1 Data collected monthly, by facility

Fig. 2 Research procedure

Table 2 Monthly data collection and in-depth interview contributors

Fig. 3 Number of study medicines stocked by various outlets, by brand status

Fig. 4 Change in stock held by the District Warehouse and a private distributor of 5 CVD medicines, January–October 2020

Fig. 5 Outpatient visits to two primary health centres, January to October 2020

Fig. 6 Absolute volume of CVD medicines dispensed at the district hospital and participating Puskesmas, by month (January–October 2020)

Fig. 7 Relative change in monthly dispensing of 5 cardiovascular medicines, January–October 2020, by sector and price of medicine

Availability of data and materials

Data on stock and distribution volumes over time by molecule, doseform, INN status, price bracket, outlet type (distributor, health facility, pharmacy) can be accessed at https://doi.org/10.7910/DVN/38AIJO, under a CC0 license. Supplementary figures uploaded to the editorial management system are additionally available using the same doi.